We are pioneering a unique set of therapeutic and drug profiling capabilities based on our revolutionary ability to 3D bioprint tissues that mimic key aspects of human biology and disease. We intend to fundamentally alter the drug discovery landscape by the development of novel therapies for disease which have a much higher chance of efficacy in the clinic focused on human primary cell 3D models of disease that more faithfully recapitulate disease processes. Learn more at www.organovo.com.
View Top Employees from Organovo Holdings, Inc.Website | http://www.organovo.com |
Ticker | ONVO |
Revenue | $3 million |
Funding | $25 million |
Employees | 43 (43 on RocketReach) |
Founded | 2007 |
Address | 11555 Sorrento Valley Rd Suite 100, San Diego, California 92121, US |
Phone | (858) 224-1000 |
Technologies |
JavaScript,
HTML,
PHP
+37 more
(view full list)
|
Industry | Biotechnology Research, Chemicals, Petrochemicals, Glass & Gases, Biotechnology, 3D bioprinting, Manufacturing, Science and Engineering, 3D printing, Medical, Drug discovery and development, Health Care, Human disease research, Therapeutics, Human disease models, Liver biology |
Web Rank | 2 Million |
Keywords | Organovo, Organovo Patents, Organovo Bioprinting, Organovo Holdings, 3d Bioprinter |
Competitors | Aspect Biosystems, BIOLIFE4D, Poietis, REGENHU, SynDaver |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Organovo Holdings, Inc. employee's phone or email?
The Organovo Holdings, Inc. annual revenue was $3 million in 2024.
Jeffrey Miner is the Chief Scientific Officer of Organovo Holdings, Inc..
43 people are employed at Organovo Holdings, Inc..
Organovo Holdings, Inc. is based in San Diego, California.
The NAICS codes for Organovo Holdings, Inc. are [54, 541714, 54171, 541, 5417].
The SIC codes for Organovo Holdings, Inc. are [873, 87].